tsh biopharmoration Ltd Capital Reinvestment Ratio
tsh biopharmoration Ltd capital reinvestment ratio. tsh biopharmoration Ltd (8432) has a Capital Reinvestment Ratio of 0.08x as of June 2025, meaning it reinvests 0% of its operating cash flow (NT$42.55 Million) in capital expenditures (NT$3.27 Million). Check tsh biopharmoration Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of tsh biopharmoration Ltd (2017–2024)
Capital reinvestment ratio of tsh biopharmoration Ltd from 2017 to 2024. This chart tracks tsh biopharmoration Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore net asset growth rate of tsh biopharmoration Ltd to track the company's year-over-year net asset growth rate.
tsh biopharmoration Ltd Capital Reinvestment Ratio by Year (2017–2024)
tsh biopharmoration Ltd capital reinvestment ratio by year from 2017 to 2024. For the full cash flow conversion analysis, see 8432 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | NT$183.77 Million | NT$2.74 Million | ▼ -90.9% |
| 2023 | 0.16x | NT$33.87 Million | NT$5.56 Million | ▼ -69.9% |
| 2022 | 0.55x | NT$34.35 Million | NT$18.73 Million | ▲ +9706.2% |
| 2021 | 0.01x | NT$68.71 Million | NT$382.00K | ▼ -97.3% |
| 2020 | 0.20x | NT$11.61 Million | NT$2.38 Million | ▲ +506.0% |
| 2019 | 0.03x | NT$88.65 Million | NT$3.00 Million | ▼ -64.0% |
| 2018 | 0.09x | NT$62.62 Million | NT$5.88 Million | ▲ +66.8% |
| 2017 | 0.06x | NT$81.13 Million | NT$4.57 Million | — |